Mechanical ventilation in newborns is a respiratory support measure to ensure ventilation for babies with respiratory failure. The goal of mechanical ventilation in newborns is to optimize oxygen and CO2 exchange, alveolar ventilation, improve blood oxygenation, reduce the work of breathing, and good coordination between the ventilator and the patient.

One of the common complications in newborns, especially low birth weight babies, is chronic lung disease. At this time, non-invasive ventilation in newborns is an optimal choice.

Non-invasive mechanical ventilation BiPAP is a method of respiratory support for patients with heart, lung, etc. problems. This method of mechanical ventilation is indicated and contraindicated for each specific case.

For patients with severe acute respiratory failure that do not respond to mechanical ventilation support and patients with acute heart failure such as acute viral myocarditis that cannot be improved by conventional treatments, the advent of the ECMO method is applied by emergency resuscitation physicians.

Invasive mechanical ventilation is a method of partially or completely supporting a patient's breathing. This is a traditional technique, ventilation through endotracheal intubation or tracheostomy for the patient.

For patients with severe acute respiratory failure that do not respond to mechanical ventilation support and patients with acute heart failure such as acute viral myocarditis that cannot be improved by conventional treatments, the advent of the ECMO method is applied by emergency resuscitation physicians.

During mechanical ventilation, a machine helps the patient breathe by delivering an air-oxygen mixture into the patient's lungs, either through an endotracheal tube or tracheostomy tube (invasive mechanical ventilation) or through a mask (non-invasive mechanical ventilation) until the patient can breathe effectively on his or her own.

COVID-19 is a SARS-CoV 2 virus, belonging to the Coronavirus family. COVID-19 spreads rapidly from person to person, with a transmission rate of about 2-3. The current mortality rate varies from country to country, from 2-3% of infected cases. Understanding of SARS-CoV2 is currently limited. There is currently no vaccine or cure.